ARTICLE |
Correspondence to: Marie-Hélène Lafage-Proust, Laboratoire de Biologie du Tissu Osseux, Faculté de Médecine, 15 Rue A. Paré, 42023 Saint-Etienne Cedex 2, France.
![]() |
Summary |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
We evaluated bromodeoxyuridine (BrdU) immunohistochemistry in undecalcified adult rat tibiae to study cell kinetics in various bone compartments: primary and secondary spongiosae, periosteum, and bone marrow. Several regimens of BrdU administration were tested (IP injections and osmotic minipumps). We compared LR White resin, methylmethacrylate, and Epon-araldite embedding, microwave irradiation for antigen retrieval, several concentrations of sodium ethoxide for deplastification, and various DNA denaturation procedures. Paraffin-embedded decalcified tibiae and Epon-embedded bowel were used as positive controls. The best results were obtained in rats labeled with 40 mg of BrdU for 72 hr using osmotic minipumps. The procedure using a Microprobe system in Epon-embedded bone tissue with a sodium ethoxide concentration of 50% for two intervals of 20 min provided the best staining quality and tissue preservation. Labeled pre-osteoblastic cells and bone marrow cells could be counted. Epon embedding allowed preservation of tetracycline double labeling performed 1 to 5 days before sacrifice. The number of labeled pre-osteoblastic cells was correlated with the double-labeled surface area measured histomorphometrically. (J Histochem Cytochem 45:1189-1195, 1997)
Key Words: bromodeoxyuridine, rat immunohistochemistry, plastic embedding, bone proliferation, osteoblast
![]() |
Introduction |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The rat is the animal model most frequently used in bone studies because it is generally accepted that secondary spongiosa of rat long bones undergoes a remodeling process at the end of the rapid growth phase. It appears increasingly necessary to evaluate in vivo effects of local and systemic factors as well as new treatments at the tissue and cellular levels. However, few studies have addressed the question of in vivo sensitivity of the various osteoblastic compartments to systemic or local factors (
The aim of our study was to develop an embedding procedure for immunohistochemistry and quantitative histomorphometry. We chose to evaluate osteoblast proliferation capacity, assessed by BrdU uptake, in various bone compartments (especially in primary and secondary spongiosae) and to compare these data with histodynamic parameters after double tetracycline labeling on the same undecalcified bone.
![]() |
Materials and Methods |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Experiment 1
Optimization of BrdU Administration and Immunohistochemistry.
Male Wistar rats (IFFA CREDO; Les Oncins, France), aged 5 weeks and weighing 192 ± 8 g, were used in this study. After 5 days of acclimatization, the animals were double labeled with tetracycline (15 mg/kg b/w.) on Day 0 and with calcein (20 mg/kg bw) on Day 5 by IP injection. BrdU (Sigma; Saint-Quentin, France) was diluted in DMSO and distilled water (v/v) at a concentration of 200 mg/ml and administered according to various protocols. One rat received an IP injection 1 h before sacrifice. Another rat received 12 IP injections (i.e., 23.5 mg/kg bw/inj) over a period of 3 days. Two rats were implanted with either one or two 1003D Azlet osmotic pumps (Charles River; Saint Aubin lès Elbeuf, France), each containing 100 µl of BrdU solution (i.e., 20 or 40 mg BrdU per animal, respectively), IP for 3 days.
Epon Embedding.
The embedding medium was prepared by mixing, in sequence, Embed 812 (12.6 g), Araldite 502 (11.8 g), DMP-30 (0.5 g), and DDSA (26.7 g) (TAAB; Saint-Germain en Laye, France) according to
After 24 hr of fixation in 70% ethanol at 4C, the samples were dehydrated in increasing ethanol concentrations. Tissues were infiltrated with increasing concentrations of Epon in propylene oxide at room temperature (RT) as follows: 25% Epon for 18 hr; 50% Epon for 24 hr; 75% Epon for 24 hr; and 100% Epon for 3 days. Polymerization was performed under vacuum at 60C for 5 days in fresh 100% Epon.
LR White Resin Embedding. After fixation overnight at 4C in 4% paraformaldehyde, 0.1% glutamine, 0.1 M phosphate buffer, the samples were rinsed in 0.1 M phosphate buffer and dehydrated in increasing ethanol concentrations. After dehydration, tissues were infiltrated with increasing concentrations of LRWhite resin (TAAB) in 70% ethanol at RT as follows: 25% LRWhite for 24 hr; 50% LRWhite for 24 hr; 75% LRWhite for 8 hr; and 100% LRWhite for 24 hr. Embedding was then performed in fresh 100% LRWhite for 7 days at 4C. Blocks were polymerized under vacuum at 50C for 5 days.
Paraffin Embedding. Samples were fixed in 4% paraformaldehyde, 0.1 M phosphate buffer, for 4 days at 4C. The bones were then decalcified in EDTA decalcifying solution (EDTA 2 Na: 41.3 g, 5% polyvinylpyrrolidone, NaOH 4.4 g; distilled water 1l). The decalcification endpoint was determined by specimen flexibility (after approximately 21 days). Bone embedding was performed according to a routine paraffin-embedding procedure.
Sectioning
Epon and LRWhite-embedded Specimens.
Each sample was polished with a circular electrical buffing wheel (Ese 200 GTL; Escil, France). Three-µm-thick sagittal sections were cut on a sledge microtome (Polycut S; Reichert-Jung, Heidelberg, Germany) with a tungsten carbide blade (Reichert-Jung 16 cm), floated in a waterbath, and mounted on positively charged slides (ProbeOn Plus slides; Fisher Scientific, Pittsburgh, PA) adapted to the MicroProbe system (Fisher Scientific) to promote tissue structure preservation, and were dried overnight at 37C in an oven.
Serial sections were performed on Epon-embedded blocks: one for immunohistochemistry and one for histomorphometry.
Paraffin-embedded Specimens. Three-µm-thick sagittal sections were cut on a microtome (Autocut 2040; Reichert-Jung) with a disposable stainless steel blade (Reichert-Jung; Buffalo, NY), floated onto 3% albumin/warm water (42-44C), and mounted on glass slides.
BrdU Immunohistochemical Staining
Preparation of Epon-embedded Sections.
Using the Microprobe system, slides were submerged in solutions of saturated sodium ethoxide diluted in 100% ethanol at different concentrations (20%, 30%, 40%, 50%, twice for 20 min, 80% for 10 min) or at a concentration of 50%, twice for 5 min, twice for 10 min, twice for 15 min, twice for 20 min to determine the best procedure to ensure optimal tissue preservation. Sodium ethoxide was used to simultaneously remove Epon and denatured DNA. The slides were then rinsed in three changes of 100% ethanol for 5 min each to eliminate sodium ethoxide, rehydrated in decreasing ethanol concentrations, and then rinsed in distilled water.
To enhance BrdU detection (
Preparation of LRWhite-embedded Sections. Slides were rehydrated with decreasing ethanol concentrations and placed in distilled water. Sections were permeabilized with 0.1% trypsin in 0.1 M HCl for 15 min at 37C, rinsed with Tris, pH 7.6, and then incubated in 4 N HCl at 56C for 30 min to denature DNA, and rinsed in 0.1 M sodium borate twice for 5 min and Tris to restore pH.
Preparation of Paraffin-embedded Sections. Slides were deparaffinized with xylene (twice for 5 min) and sections were then rehydrated and placed in distilled water. Sections were rinsed with Tris, pH 7.6, and incubated in 4 N HCl at 56C for 30 min to denature DNA, rinsed in 0.1 M sodium borate twice for 5 min and Tris to restore pH.
Staining Procedure. After each step, sections were rinsed in Tris, pH 7.6, twice for 5 min, then in Tris/BSA 1%, pH 7.6. Endogenous peroxidases were blocked with 3% H2O2 for 30 min. Sections were then incubated at RT with primary antibody (anti-BrdU; Sigma) for 1 hr. The primary antibody was revealed with a kit (Immunotech; Marseille, France) using streptavidin conjugate and DAB as chromogen. Sections were incubated with biotinylated goat anti-mouse IgG for 30 min at RT and incubated with streptavidin-peroxidase conjugate for 45 min at RT, then with DAB chromogen mixture for 20 min, and finally rinsed thoroughly in distilled water. Hematoxylin counterstaining was performed for 2 min. Sections were then rinsed with tapwater and mounted.
Evaluation. The immunostained slides were observed under light microscopy at magnifications of x 40 and x 100. The entire bone sections were observed for the localization of BrdU-labeled cells. BrdU-positive cell types were determined by observing dark brown DAB nuclear staining. Unlabeled nuclei with only blue hematoxylin staining and pale brownish nuclei were considered to be negative.
Controls.
Positive controls consisted of bowel immunostaining, designed to assess correct function of the osmotic minipumps. To verify the absence of interference of our deplastification technique with the immunostaining with another antibody, we performed the full procedure using anti-smooth muscle -actin as primary antibody.
Three types of negative controls were designed: the complete immunohistochemistry procedure performed on bones from rats not submitted to BrdU administration and the complete procedure omitting primary antibody or using a nonimmune primary antibody on bones from BrdU labeled rats.
Experiment 2
Comparison of BrdU-labeled Pre-osteoblasts with Histodynamic Parameters.
After defining the optimal procedure, six male Wistar rats were used for a 6-day experiment. Animals were double labeled with tetracycline (15 mg/kg bw) on Day 1 and with calcein (20 mg/kg bw) on Day 5 by IP injection. They were implanted on Day 4 with two 1003D Azlet osmotic minipumps each containing 100 µl of BrdU solution (40 mg of BrdU per animal). Animals were sacrificed with an anesthetic overdose (Nesdonal 0.1 mg/kg) at the end of Day 6. The duration of BrdU labeling was therefore 72 hr. The left tibiae were dissected for "conventional" histomorphometry and the right tibiae and a bowel segment were prepared for immunohistochemistry.
Processing For Bone Histomorphometry.
After sacrifice, the left tibiae were excised, fixed, dehydrated in absolute acetone, embedded mineralized in methylmethacrylate, and sagitally sectioned at a thickness of 7 µm for subsequent bone histomorphometry measurements. A Leitz-TAS+ automatic image analyzer equipped with a Bosch camera connected to a Leitz Orthoplan microscope was used to determine bone surfaces (BS/TV) in the primary and secondary spongiosae. These measurements were performed on six modified Goldner sections. Histodynamic measurements were performed with a semiautomatic system composed of a digitizing table (Summasketch-Summagraphics) connected to a personal computer and to a Reichert Polyvar microscope equipped with a drawing system (Camera Lucida). The following parameters were measured on unstained 6-µm-thick sections under UV light: mineral apposition rate (MAR, µm/day) single- and double-labeled surface area (sLS/BS and dLS/BS, %). Left tibiae were embedded in Epon and processed according to the final procedure described earlier. Labeled osteogenic precursors, regardless of their type, were counted in primary spongiosa using a square grid. Their number was expressed in relation to the bone/cartilage area measured on the automatic image analyzer. In secondary spongiosa, labeled pre-osteoblasts were counted and their number expressed in relation to the bone perimeter. Only dark-brown nuclei were taken into account. Pre-osteoblasts were defined, as previously described (
|
![]() |
Results |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Staining specificity was confirmed, as the immunohistochemistry negative controls did not show any significant nuclear labeling. Immunostaining quality was determined by staining intensity in comparison with background staining.
Experiment 1
BrdU Regimen.
No BrdU labeling was observed in the secondary spongiosa pre-osteoblasts of tibiae from rats receiving one or multiple IP injections.
Continuous BrdU administration by osmotic pumps allowed labeling of proliferative pre-osteoblasts in bone. However, two osmotic pumps provided a better staining signal and an increased number of labeled cells compared to rats implanted with one pump.
BrdU Staining of Paraffin-embedded Tissues. In the small intestine, nuclei of crypt epithelial cells were BrdU labeled. BrdU labeling was seen in bone marrow cells (Figure 1A) and in chondrocytes of the proliferative zone of the growth plate. BrdU-labeled proliferating preosteoblasts were visible on the surface of trabecular bone.
BrdU Staining of LR White-embedded Tissues
Bone Specimen.
As in paraffin-embedded bones, few proliferating pre-osteoblasts were labeled over the surface of trabecular bone. However, DNA denaturation by 4 N HCl at 56C for 30 min induced disruption of bone sections and morphological details were poorly preserved (Figure 1B). A degree of shrinkage and ruffling of sections was also observed during the immunostaining procedure. For these reasons, consistently good results were not obtained with this resin embedding.
BrdU Staining of Epon-embedded Tissues. BrdU staining was similar to that in paraffin-embedded small intestine. The staining result was consistent throughout the section. The sodium ethoxide concentrations that allowed complete deplastification of slides of bone sections were 50% twice for 20 min and 80% for 10 min. However, the 80% concentration did not ensure sufficient tissue preservation. When lower concentrations were used, Epon was not completely removed and BrdU-labeled cells were occasionally observed in bone marrow. The stained cells were not evenly distributed throughout the section. Deplastification with a 50% sodium ethoxide solution (twice for 20 min) combined with the use of the Microprobe system provided flat sections that remained adherent to the slides throughout the staining procedure (5 hr). In this case, BrdU uptake in bone marrow cells was comparable to that of paraffin-embedded cells (Figure 1C). Preosteoblasts were observed in the perichondrium and periosteum (Figure 2A), close to the surface of trabecular bone in the secondary spongiosa (Figure 2C) of the tibial metaphysis. Labeled chondrocytes were found in the proliferative zone (Figure 2B) of the growth plate. Few BrdU-positive osteoclasts (Figure 2D) were observed, and only two to three labeled osteocytes were seen on each section.
|
The use of microwave irradiation to enhance BrdU staining induced shrinkage and damage to bone sections. Morphological details were poorly visualized and background was higher. Conventional histomorphometry was performed on these Epon-embedded sections, as the toluidine blue staining was comparable to that obtained on MMA sections (Figure 3A). Double tetracycline labeling was visible under UV light, allowing histodynamic measurements (Figure 3B). Immunostaining of vessels with anti-smooth muscle -actin antibody after the deplastification procedure was positive, with very low background (Figure 3C).
|
Experiment 2
In Epon-embedded tibiae, the number of labeled pre-osteoblasts per mm of bone perimeter in secondary spongiosa was 1.70 ± 0.16/mm2 and the number of osteogenic precursors in primary spongiosa was 6.77 10-6 ± 0.81/mm2 of bone/cartilage area. Approximately 20.6 ± 3.2/mm2 dividing cells were detected in bone marrow. The coefficients of variation of the measurements were 19.1% and 29.2% in secondary spongiosa and bone marrow, respectively.
Histodynamic Measurements. On Epon-embedded sections, mineral apposition rate was 3.54 ± 0.8 µm/d: the single-labeled surface (sLS/BS) = 14.2 ± 3.2% and the double-labeled surface (dLS/BS) = 29.9 ± 6.2%. With MMA, MAR was 3.22 ± 0.4 µm/d: sLS/BS was 12.1 ± 2.7% and dLS/BS was 26.3 ± 5.1%. The histodynamic measurements of labeled surfaces were positively correlated between MMA and EPON (slS/BS r2 = 0.52, p<0.1; dLS/BS r2 = 0.86, p<0.01). Labeled surfaces were higher with Epon than with MMA, but the difference was not statistically significant. This difference was probably related to the fact that Epon sections were more ruffled than MMA sections. Linear regression analysis showed a positive relationship between double-labeled surface and BrdU-labeled pre-osteoblasts in secondary spongiosa (y = 0.03 x 0.95, r = 0.87, p<0.01), demonstrating that, under physiological conditions, the mineralizing surface provides a fairly accurate estimation of pre-osteoblast proliferation.
![]() |
Discussion |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Because our aim was to perform quantitative evaluation of BrdU-labeled cells, preservation of tissue architecture and homogeneous immunolabeling throughout the section were mandatory, as emphasized by
We found that the best results in terms of tissue preservation were obtained with a sodium ethoxide concentration of 50% twice for 20 min combined with Microprobe. The use of 100% sodium ethoxide for 20 min, as recommended by
The coefficient of variation in secondary spongiosa was 19.1%, which is an acceptable level of precision in view of those found in coventional quantitative bone histomorphometry (
Normal remodeling rat bone has a relatively low turnover compared to healing cortical fracture, intestine, or tumors. Unlike growth plate proliferative chondrocytes, pre-osteoblasts (
We found a positive correlation between the number of BrdU-labeled pre-osteoblasts in the secondary spongiosa and the fluorochrome-labeled surface measured under UV light. The tetracycline-labeled surface reflects the number of osteoblasts participating in the calcification process (
In conclusion, we have developed and improved a technique that allows visualization of dividing pre-osteoblasts in various compartments of adult rat metaphysis and provides reliable measurements, at least in primary and secondary spongiosa. Identification of osteoblastic precursors within the bone marrow, as performed by FACS analysis (
![]() |
Acknowledgments |
---|
We would like to thank Dr J. F. Mosnier for helpful discussion and advice.
Received for publication November 5, 1996; accepted April 2, 1997.
![]() |
Literature Cited |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Apte AA, Puddle B (1990) Bromodeoxyuridine immunohistochemistry in undecalcified plastic-embedded tissue. Elimination of the DNA denaturation step. Histochemistry 93:631-635 [Medline]
Bernhards J, Weitzel B, Werner M, Rimpler M, Georgii A (1992) A new histological embedding method by low temperature polymerization of methylmethacrylate allowing immuno- and enzyme histochemical studies on semi-thin sections of undecalcified bone marrow biopsies. Histochemistry 98:145-154 [Medline]
Bianco P, Riminucci M, Bonucci E, Termine JD, Gehron Robey P (1993) Bone sialoprotein (BSP) secretion and osteoblast differentiation: relationship to bromodeoxyuridine incorporation, alkaline phosphatase and matrix deposition. J Histochem Cytochem 41:183-191
Bourque WT, Gross M, Hall BK (1992) A histological processing technique that preserves the integrity of calcified tissue (bone-enamel), yolky amphibian embryos, and growth factor antigens in skeletal tissue. J Histochem Cytochem 41:1429-1434
Chavassieux P, Arlot M, Meunier PJ (1985) Intersample variation in bone histomorphometry: comparison between parameter values measured on two contiguous transiliac bone biopsies. Calcif Tissue Int 37:345-350 [Medline]
Dobnig H, Turner RT (1995) Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells. Endocrinology 136:3662-3638
Dover R, Patel K (1994) Improved methodology for detecting bromodeoxyuridine in cultured cells and tissue sections by immunocytochemistry. Histochemistry 102:383-387 [Medline]
Fallon MD, Teitelbaum SL (1982) The interpretation of fluorescent tetracycline markers in the diagnostic of metabolic bone disease. Hum Pathol 13:416-418 [Medline]
Farnum CE, Wilsman NJ (1993) Determination of proliferative characteristics of growth plate chondrocytes by labeling with bromodeoxyuridine. Calcif Tissue Int 52:110-119 [Medline]
Frank JD, Balena R, Masarachia P, Seedor GJ, Cartwight ME (1993a) The effects of three different demineralization agents on osteopontin localization in adult rat bone using immunohistochemistry. Histochemistry 99:295-301 [Medline]
Frank JD, Cartwight ME, Keenan KP (1993b) Intensification of 5-bromodeoxyuridine immunohistochemistry with zinc buffered formalin postfixation and ABC Elite solution. J Histotechnol 16:329-334
Friedenstein AJ (1976) Precursor cells of mecanocytes. Int Rev Cytol 47:327-359 [Medline]
Groot CG, Danes JK, Hoogendijk A, Hauschka PV (1986) Light and electron microscopic demonstration of osteocalcin antigenicity in embryonic and adult rat bone. Bone 7:379-385 [Medline]
Ingram RT, Clarke BL, Fisher LW, Fitzpatrick LA (1993) Distribution of non collagenous proteins in the matrix of adult human bone: evidence of anatomic and functional heterogeneity. J Bone Miner Res 8:1019-1028 [Medline]
Kember NF (1960) Cell division in endochrondral ossification. A study of cell proliferation in rat bones by the method of tritiated thymidine autoradiography. J Bone Joint Surg [Br] 42:824-839
Kimmel DB, Jee WSSJ (1980) Bone cell kinetics in longitudinal bone growth in the rat. Calcif Tissue Int 32:123-133 [Medline]
Margaud JP, Sargent I, Clarke PJ, French M, Romokh R, Mason DY (1989) Double immunohistochemical labeling of cell and tissue samples with monoclonal anti-bromodeoxyuridine. J Histochem Cytochem 37:15-17 [Abstract]
Mullink H, Henzen-Logmans SC, Tadema TM, Mol JJ, Meijer CJLM (1985) Influence of fixation and decalcification on the immunohistochemical staining of cell-specific markers in paraffin-embedded human bone biopsies. J Histochem Cytochem 33:1103-1109 [Abstract]
Oprins AD, Geuze H, Slot JW (1994) Cryosubstitution dehydration of aldehyde-fixed tissue: a favorable approach to quantitative immunohistochemistry. J Histochem Cytochem 42:497-503
Owen M (1963) Cell population kinetics of an osteogenic tissue. J Cell Biol 19:19-32
Parfitt AM (1983) Stereologic basis of bone histomorphometry: theory of quantitative microscopy and reconstruction of the third dimension. In Recker RR, ed. Bone Histomorphometry: Techniques and Interpretation. Boca Raton, FL, CRC Press, 53-59
Roberts WE, Fiedler ML, Rosenoer AC, Maese AC, Gonsalves MR, Morey ER (1987) Nuclear morphometry analysis of osteoblasts precursor cells in peridontal ligaments in SLS-3 rats. Am J Physiol 252:R247-R251
Tamatani R, Taniguchi Y, Kawarai Y (1995) Ultrastructural study of proliferating cells with an improved immunocytochemical detection of DNA-incorporated bromodeoxyuridine. J Histochem Cytochem 43:21-29
Tischler AS (1995) Triple immunohistochemical staining for bromodeoxyuridine and catecholamine biosynthetic enzymes using microwave antigen retrieval. J Histochem Cytochem 43:1-4
Turner RT, Backup P, Sherman PJ, Hill E, Evans GL, Spelsberg TC (1992) Mechanism of action of oestrogen on intramembranous bone formation: regulation of osteoblast differentiation and activity. Endocrinology 131:883-889 [Abstract]
Van de Kant HJG, Van Pelt AMM, Vergouwen RPFA, De Rooïj DG (1990) A rapid immunogold silver staining for detection of bromodeoxyuridine in a large number of plastic sections, using microwave irradiation. Histochem J 22:321-326 [Medline]
Van Vlasselaer P, Falla N, Snoeck H, Mathieu E (1994) Characterization and purification of osteogenic cells from murine bone marrow by two-color cell sorting using anti-sac-1 monoclonal antibody and wheat germ agglutinin. Blood 84:753-763
Xiang Z, Markel M (1995) Bromodeoxyuridine immunohistochemistry of Epon-embedded undecalcified bone in a canine fracture healing model. J Histochem Cytochem 43:629-635
Young RW (1962) Regional differences in cell generation time in growing rat tibiae. Exp Cell Res 26:562-567